09:00 AM EDT, 05/24/2024 (MT Newswires) -- Health care stocks were steady pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) inactive and the iShares Biotechnology ETF (IBB) up 0.1%.

Guardant Health ( GH ) stock was over 16% higher after the company said that a panel of the US Food and Drug Administration's Medical Devices Advisory Committee recommended approval of the company's Shield blood test for colorectal cancer screening in adults who are at least 45 years old and at average risk for the disease.